Pharmaceuticals Global Group of Eight (G8) Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025
Summary
The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The G8 countries contributed $681.2 billion in 2020 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 4.7% between 2016 and 2020. The G8 countries are expected to reach a value of $788.1 billion in 2025, with a CAGR of 3% over the 2020-25 period.
- Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $387.0 billion in 2020. This was followed by Japan and Germany, with a value of $87.0 and $71.3 billion, respectively.
- The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $441.0 billion in 2016, followed by Japan and Germany with expected values of $100.9 and $98.5 billion, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players' G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
Reasons to Buy
- What was the size of the G8 pharmaceuticals market by value in 2020?
- What will be the size of the G8 pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the G8 pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the G8 pharmaceuticals market?
Pharmaceuticals Global Group of Eight (G8) Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025
Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Group of Eight (G8) Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 Pharmaceuticals in France
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators
5 Pharmaceuticals in Germany
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 Pharmaceuticals in Italy
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 Pharmaceuticals in Japan
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators
8 Pharmaceuticals in Russia
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
8.6. Macroeconomic Indicators
9 Pharmaceuticals in The United Kingdom
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
9.6. Macroeconomic Indicators
10 Pharmaceuticals in The United States
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
10.6. Macroeconomic Indicators
11 Company Profiles
11.1. Johnson & Johnson
11.2. Pfizer Inc.
11.3. Apotex, Inc.
11.4. Merck & Co., Inc.
11.5. Sanofi SA
11.6. Laboratoires Pierre Fabre SA
11.7. F. Hoffmann-La Roche Ltd
11.8. Boehringer Ingelheim GmbH
11.9. A Menarini Industrie Farmaceutiche Riunite Srl
11.10. Chiesi Farmaceutici SpA
11.11. Recordati S.p.A.
11.12. Daiichi Sankyo Co Ltd
11.13. Astellas Pharma Inc.
11.14. Mitsubishi Tanabe Pharma Corporation
11.15. Takeda Pharmaceutical Company Limited
11.16. Bayer AG
11.17. Les Laboratoires Servier
11.18. Novartis AG
11.19. GlaxoSmithKline Plc
11.20. AstraZeneca PLC
12 Appendix
12.1. Methodology
12.2. About MarketLine
List of Tables
Table 1: G8 pharmaceuticals industry, revenue($bn), 2016-25
Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2016-20
Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2020-25
Table 4: Canada pharmaceuticals market value: $ billion, 2016-20
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2020
Table 6: Canada pharmaceuticals market share: % share, by value, 2020
Table 7: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Table 8: Canada size of population (million), 2016-20
Table 9: Canada gdp (constant 2005 prices, $ billion), 2016-20
Table 10: Canada gdp (current prices, $ billion), 2016-20
Table 11: Canada inflation, 2016-20
Table 12: Canada consumer price index (absolute), 2016-20
Table 13: Canada exchange rate, 2016-20
Table 14: France pharmaceuticals market value: $ billion, 2016-20
Table 15: France pharmaceuticals market geography segmentation: $ billion, 2020
Table 16: France pharmaceuticals market share: % share, by value, 2020
Table 17: France pharmaceuticals market value forecast: $ billion, 2020-25
Table 18: France size of population (million), 2016-20
Table 19: France gdp (constant 2005 prices, $ billion), 2016-20
Table 20: France gdp (current prices, $ billion), 2016-20
Table 21: France inflation, 2016-20
Table 22: France consumer price index (absolute), 2016-20
Table 23: France exchange rate, 2016-20
Table 24: Germany pharmaceuticals market value: $ billion, 2016-20
Table 25: Germany pharmaceuticals market geography segmentation: $ billion, 2020
Table 26: Germany pharmaceuticals market share: % share, by value, 2020
Table 27: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Table 28: Germany size of population (million), 2016-20
Table 29: Germany gdp (constant 2005 prices, $ billion), 2016-20
Table 30: Germany gdp (current prices, $ billion), 2016-20
Table 31: Germany inflation, 2016-20
Table 32: Germany consumer price index (absolute), 2016-20
Table 33: Germany exchange rate, 2016-20
Table 34: Italy pharmaceuticals market value: $ billion, 2016-20
Table 35: Italy pharmaceuticals market geography segmentation: $ billion, 2020
Table 36: Italy pharmaceuticals market share: % share, by value, 2020
Table 37: Italy pharmaceuticals market value forecast: $ billion, 2020-25
Table 38: Italy size of population (million), 2016-20
Table 39: Italy gdp (constant 2005 prices, $ billion), 2016-20
Table 40: Italy gdp (current prices, $ billion), 2016-20
Table 41: Italy inflation, 2016-20
Table 42: Italy consumer price index (absolute), 2016-20
Table 43: Italy exchange rate, 2016-20
Table 44: Japan pharmaceuticals market value: $ billion, 2016-20
Table 45: Japan pharmaceuticals market geography segmentation: $ billion, 2020
Table 46: Japan pharmaceuticals market share: % share, by value, 2020
Table 47: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Table 48: Japan size of population (million), 2016-20
Table 49: Japan gdp (constant 2005 prices, $ billion), 2016-20
Table 50: Japan gdp (current prices, $ billion), 2016-20
Table 51: Japan inflation, 2016-20
Table 52: Japan consumer price index (absolute), 2016-20
Table 53: Japan exchange rate, 2016-20
Table 54: Russia pharmaceuticals market value: $ billion, 2016-20
Table 55: Russia pharmaceuticals market geography segmentation: $ billion, 2020
Table 56: Russia pharmaceuticals market share: % share, by value, 2020
Table 57: Russia pharmaceuticals market value forecast: $ billion, 2020-25
Table 58: Russia size of population (million), 2016-20
Table 59: Russia gdp (constant 2005 prices, $ billion), 2016-20
Table 60: Russia gdp (current prices, $ billion), 2016-20
Table 61: Russia inflation, 2016-20
Table 62: Russia consumer price index (absolute), 2016-20
Table 63: Russia exchange rate, 2016-20
Table 64: United Kingdom pharmaceuticals market value: $ billion, 2016-20
Table 65: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2020
Table 66: United Kingdom pharmaceuticals market share: % share, by value, 2020
Table 67: United Kingdom pharmaceuticals market value forecast: $ billion, 2020-25
Table 68: United Kingdom size of population (million), 2016-20
Table 69: United Kingdom gdp (constant 2005 prices, $ billion), 2016-20
Table 70: United Kingdom gdp (current prices, $ billion), 2016-20
Table 71: United Kingdom inflation, 2016-20
Table 72: United Kingdom consumer price index (absolute), 2016-20
List of Figures
Figure 1: G8 pharmaceuticals industry, revenue($bn), 2016-25
Figure 2: G8 Pharmaceuticals industry, revenue by country (%), 2020
Figure 3: G8 pharmaceuticals industry, revenue by country ($bn), 2016-20
Figure 4: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2020-25
Figure 5: Canada pharmaceuticals market value: $ billion, 2016-20
Figure 6: Canada pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 7: Canada pharmaceuticals market share: % share, by value, 2020
Figure 8: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Figure 9: Forces driving competition in the pharmaceuticals market in Canada, 2020
Figure 10: Drivers of buyer power in the pharmaceuticals market in Canada, 2020
Figure 11: Drivers of supplier power in the pharmaceuticals market in Canada, 2020
Figure 12: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2020
Figure 13: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2020
Figure 14: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2020
Figure 15: France pharmaceuticals market value: $ billion, 2016-20
Figure 16: France pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 17: France pharmaceuticals market share: % share, by value, 2020
Figure 18: France pharmaceuticals market value forecast: $ billion, 2020-25
Figure 19: Forces driving competition in the pharmaceuticals market in France, 2020
Figure 20: Drivers of buyer power in the pharmaceuticals market in France, 2020
Figure 21: Drivers of supplier power in the pharmaceuticals market in France, 2020
Figure 22: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2020
Figure 23: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2020
Figure 24: Drivers of degree of rivalry in the pharmaceuticals market in France, 2020
Figure 25: Germany pharmaceuticals market value: $ billion, 2016-20
Figure 26: Germany pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 27: Germany pharmaceuticals market share: % share, by value, 2020
Figure 28: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Figure 29: Forces driving competition in the pharmaceuticals market in Germany, 2020
Figure 30: Drivers of buyer power in the pharmaceuticals market in Germany, 2020
Figure 31: Drivers of supplier power in the pharmaceuticals market in Germany, 2020
Figure 32: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2020
Figure 33: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2020
Figure 34: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2020
Figure 35: Italy pharmaceuticals market value: $ billion, 2016-20
Figure 36: Italy pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 37: Italy pharmaceuticals market share: % share, by value, 2020
Figure 38: Italy pharmaceuticals market value forecast: $ billion, 2020-25
Figure 39: Forces driving competition in the pharmaceuticals market in Italy, 2020
Figure 40: Drivers of buyer power in the pharmaceuticals market in Italy, 2020
Figure 41: Drivers of supplier power in the pharmaceuticals market in Italy, 2020
Figure 42: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2020
Figure 43: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2020
Figure 44: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2020
Figure 45: Japan pharmaceuticals market value: $ billion, 2016-20
Figure 46: Japan pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 47: Japan pharmaceuticals market share: % share, by value, 2020
Figure 48: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Figure 49: Forces driving competition in the pharmaceuticals market in Japan, 2020
Figure 50: Drivers of buyer power in the pharmaceuticals market in Japan, 2020
Figure 51: Drivers of supplier power in the pharmaceuticals market in Japan, 2020
Figure 52: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2020
Figure 53: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2020
Figure 54: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2020
Figure 55: Russia pharmaceuticals market value: $ billion, 2016-20
Figure 56: Russia pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 57: Russia pharmaceuticals market share: % share, by value, 2020
Figure 58: Russia pharmaceuticals market value forecast: $ billion, 2020-25
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
